One of North America’s largest IRBs

Headquartered in Cincinnati, Ohio, Schulman Associates IRB is an independent institutional review board overseeing the review of research protocols and consent documents used to protect human subjects participating in pharmaceutical, biotech and medical device trials. Schulman was acquired by Imperial Capital in 2008 and was sold in 2014.





Investment Date2008 – Fund IV


StatusRealized – 2014


HeadquartersCincinnati, OH


MarketsU.S., Puerto Rico and Canada

Imperial LeadJeffrey Rosenthal Managing Partner

Your Company, Your Idea, Your Partner

We are always looking for new partnership opportunities and seeking to help build better businesses. If you are the founder of a business that is poised for growth, a seasoned executive that has a great idea for an industry to invest in or an entrepreneur that wants to launch a business, we should talk.

Your request has been sent.